New Therapies Targeting apoB Metabolism for High-Risk Patients with Inherited Dyslipidaemias: What Can the Clinician Expect?

Overview of attention for article published in Cardiovascular Drugs and Therapy, August 2013

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 139 Dimensions

Readers on

mendeley: 63 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 57,462 followers.

@LDLSkeptic @lowcarbusa Also found this review stating 8-55% reductions in Lp(a) with PCSK9i. In the current context, there are certain people I'd at least prefer to be on those than lipophilic statins https://t.co/jhlUnHT16f

15 Jan 2021

Reply Repost Favourite

New Therapies Targeting apoB Metabolism http://t.co/biW0zzRgMK

12 Aug 2013

Reply Repost Favourite

New Therapies Targeting apoB Metabolism Apolipoprotein B (apoB) has a key role in the assembly and secretion of... http://t.co/L4OFX4eZAI

06 Aug 2013

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.